SCHEMBL7701481

SCHEMBL7701481

CCN(CC)CCNC(=O)COc1c[c]ccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.63
CYP2D6 P10635 1/20 0.63
CYP3A4 P08684 1/20 0.62
KDM4E B2RXH2 3/20 0.43
TSHR P16473 1/20 0.43
RECQL P46063 1/20 0.43
HPGD P15428 2/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 2/20 0.41
LGALS1 P09382 1/20 0.41
PTPN1 P18031 1/20 0.41
MCHR1 Q99705 1/20 0.41
ALDH1A1 P00352 1/20 0.40
NPC1 O15118 1/20 0.40
USP2 O75604 1/20 0.40
MEN1 O00255 1/20 0.40
PPARG P37231 1/20 0.40
HTT P42858 1/20 0.40
NCOA2 Q15596 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7001340 0.87 SMN1; SMN2 (0.49) CYP1A2CYP2D6CYP3A4KDM4ERECQL
SCHEMBL7002893 0.84 CYP1A2 (0.73) CYP1A2CYP2D6CYP3A4KDM4ETSHR
SCHEMBL14694031 0.79 TSHR (0.56) CYP1A2KDM4ETSHRRECQLHPGD
Mefexamide SCHEMBL126334 0.78 CYP1A2 (1.00) CYP1A2CYP2D6CYP3A4KDM4EPTPN1
SCHEMBL6293325 0.77 KMT2A (0.45) RECQLHPGDKMT2ANPC1MEN1
Clofexamide SCHEMBL1604514 0.76 CYP1A2 (0.78) CYP1A2CYP2D6CYP3A4KDM4ECYP2C9
Mefexamide SCHEMBL364170 0.76 CYP3A4 (1.00) CYP1A2CYP2D6CYP3A4KDM4EPTPN1
SCHEMBL14694132 0.76 KMT2A (0.48) CYP1A2HPGDCYP2C9CYP2C19KMT2A
Mefexamide SCHEMBL1650022 0.75 CYP1A2 (0.95) CYP1A2CYP2D6CYP3A4KDM4EPTPN1
Clofexamide SCHEMBL365077 0.75 CYP3A4 (0.78) CYP1A2CYP2D6CYP3A4KDM4ECYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1335836-A Tricyclic pyrazole derivatives BASF AG (DE) 2002-02-13 CN claimed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
CN-1368970-A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase KNOLL GMBH (DE) 2002-09-11 CN disclosed
CN-1335836-A Tricyclic pyrazole derivatives BASF AG (DE) 2002-02-13 CN disclosed